Cite
Savio E, Ures MC, Zeledón P, et al. 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates. BMC Nucl Med. 2004;4(1):1doi: 10.1186/1471-2385-4-1.
Savio, E., Ures, M. C., Zeledón, P., Trindade, V., Paolino, A., Mockford, V., Malanga, A., Fernández, M., & Gaudiano, J. (2004). 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates. BMC nuclear medicine, 4(1), 1. https://doi.org/10.1186/1471-2385-4-1
Savio, Eduardo, et al. "188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates." BMC nuclear medicine vol. 4,1 (2004): 1. doi: https://doi.org/10.1186/1471-2385-4-1
Savio E, Ures MC, Zeledón P, Trindade V, Paolino A, Mockford V, Malanga A, Fernández M, Gaudiano J. 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates. BMC Nucl Med. 2004 Jan 30;4(1):1. doi: 10.1186/1471-2385-4-1. PMID: 15040807; PMCID: PMC373254.
Copy
Download .nbib